How socioeconomic factors affect outcomes in this deadly cancer

This article explores how socioeconomic factors influence outcomes in hormone receptor-positive (HR+) breast cancer, a common and deadly type of cancer affecting women globally. Researchers from the University of Pennsylvania discovered that Black women diagnosed with HR+ breast cancer experience worse outcomes compared to white women.

While genetics plays a significant role in health disparities for many diseases, the study reveals that lifestyle factors and social determinants, such as poverty burden and structural disadvantages, play a more substantial role in the outcomes of Black women with HR+ breast cancer.

The research, published in the journal Cancer Research, focused on differences in collagen architecture between Black and white women's breast tissues. Collagen, a protein that provides structural support to tissues, was found to have a different pattern in Black women, which affects how cancer cells metastasize or spread. Interestingly, when white women's cells were placed in the collagen architecture of Black women, they stopped metastasizing, suggesting that the collagen pattern itself contributes to the disparity in outcomes.

Another key finding is that the immune response in Black women's tumors is different from that in white women's tumors. While Black women's tumors contain more immune cells, these cells are less effective at killing cancer cells. In contrast, white women's tumors have fewer immune cells but are more efficient at killing cancer cells.

This difference in immune response is not solely attributed to race or ancestry but is instead linked to socioeconomic conditions, such as poverty burden. The study found that white women facing high poverty burdens also exhibited the same problematic immune response, indicating that socioeconomic factors play a crucial role in shaping the immune profile of cancer patients.

Haricharan, the lead researcher, emphasizes that the study challenges the conventional understanding of cancer disparities, which often attribute them to racial or genetic differences. Instead, the research suggests that social determinants, particularly socioeconomic conditions, are more closely associated with the observed disparities in HR+ breast cancer outcomes.

The findings highlight the need for a more holistic approach to cancer research, considering not only genetic and biological factors but also the broader socio-economic context in which patients live. By incorporating data on life experiences and social determinants, researchers can develop a more comprehensive understanding of cancer biology and improve the precision and equity of cancer treatments.